Novo Nordisk posts results for Phase 3 dasiglucagon and liraglutide pediatric trialsNov 16Weekly roundup, 3 itemsliraglutideNovo Nordisk A/S
Novo Nordisk registers four Phase 3 AMBITION trials for zenagamtide in type 2 diabetesNov 12Weekly roundup, 5 itemsNovo Nordisk A/SsemaglutideUpdated
Novo Nordisk registers Phase 3 CagriSema hypertension trial; posts results for two other studiesNov 6Weekly roundup, 4 itemsCagrisemaNNC0487-0111Updated
Ginkgo Bioworks reports Q3 2026 results, announces first autonomous lab sale to NovoNov 5Quarterly updateGinkgo Bioworks Holdings, Inc.Novo Nordisk A/SUpdated
Korro Bio starts dosing in KRRO-121 trial, faces Novo Nordisk terminationNov 5Quarterly updateKorro Bio, Inc.KRRO-121
Novo Nordisk: BARI-STEP semaglutide trial results posted; two new Phase 1 studies registeredOct 28Weekly roundup, 7 itemsconcizumabdenecimig
FDA approves efficacy supplement for Novo Nordisk's Awiqli FlexTouchOct 23Regulatory decisioninsulin icodecNovo Nordisk A/S
Novo Nordisk registers real-world semaglutide study with Eucalyptus in AustraliaOct 19Trial updateNovo Nordisk A/Ssemaglutide
Novo Nordisk registers two zenagamtide switch studies; IMPLEMENT HF recruitment continuesOct 16Weekly roundup, 3 itemsNovo Nordisk A/SsemaglutideUpdated
Novo Nordisk registers Phase 3 cardiovascular outcomes trial for zenagamtide, acronym AMBIENCEOct 9Weekly roundup, 2 itemsNovo Nordisk A/Stirzepatide
Novo Nordisk adds four registrations: new molecule trial, CagriSema switch study, real-world dataOct 2Weekly roundup, 9 itemsCagrisemaNNC0705-0002Updated
Novo Nordisk registers Phase 3 trial for denecimig in acquired haemophilia A, plus new Phase 1 studySep 25Weekly roundup, 3 itemsdenecimigNNC0642-1895Updated
Novo Nordisk registers Phase 3 obesity trial in Japan; new CagriSema switch studySep 16Weekly roundup, 2 itemsCagrisemaNNC0487-0111
Novo Nordisk registers two Phase 1 PK trials for zenagamtide and NNC0537-1482Sep 11Weekly roundup, 2 itemsNNC0537-1482Novo Nordisk A/S
Novo Nordisk registers Phase 3 zenagamtide trial in T2D and first-in-human study for NNC0705-0002Sep 1Weekly roundup, 2 itemsNNC0705-0002Novo Nordisk A/S
Novo Nordisk registers real-world cardiometabolic study using Turkish EHR dataAug 24Trial updateNovo Nordisk A/S
Novo Nordisk posts PIONEER TEENS results; registers three new trials for obesity and injectionsAug 21Weekly roundup, 4 itemsNNC0721-8060Novo Nordisk A/S
Novo Nordisk posts results for two semaglutide trials, opens new NNC0487-0111 studyAug 14Weekly roundup, 3 itemsNNC0487-0111Novo Nordisk A/S
Novo Nordisk registers Phase 3 cagrilintide trial; Penn semaglutide study posts resultsAug 4Weekly roundup, 2 itemscagrilintideNovo Nordisk A/S
Novo Nordisk registers Korean MASLD/MASH real-world study and semaglutide back pain trialJul 31Weekly roundup, 2 itemsNovo Nordisk A/Ssemaglutide